Does the media refer more to CLOV or HQY?

In the previous week, HealthEquity had 11 more articles in the media than Clover Health Investments. MarketBeat recorded 13 mentions for HealthEquity and 2 mentions for Clover Health Investments. HealthEquity's average media sentiment score of 1.40 beat Clover Health Investments' score of -0.30 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral HealthEquity 10 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ALHC or CLOV?

In the previous week, Alignment Healthcare had 19 more articles in the media than Clover Health Investments. MarketBeat recorded 21 mentions for Alignment Healthcare and 2 mentions for Clover Health Investments. Alignment Healthcare's average media sentiment score of 0.21 beat Clover Health Investments' score of -0.30 indicating that Alignment Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alignment Healthcare 7 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 4 Very Negative mention(s) Neutral Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CLOV or UNH?

In the previous week, UnitedHealth Group had 83 more articles in the media than Clover Health Investments. MarketBeat recorded 85 mentions for UnitedHealth Group and 2 mentions for Clover Health Investments. UnitedHealth Group's average media sentiment score of 1.26 beat Clover Health Investments' score of -0.30 indicating that UnitedHealth Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral UnitedHealth Group 65 Very Positive mention(s) 8 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 3 Very Negative mention(s) Positive

Does the media prefer ELV or CLOV?

In the previous week, Elevance Health had 39 more articles in the media than Clover Health Investments. MarketBeat recorded 41 mentions for Elevance Health and 2 mentions for Clover Health Investments. Elevance Health's average media sentiment score of 1.70 beat Clover Health Investments' score of -0.30 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 40 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CLOV or HUM?

In the previous week, Humana had 17 more articles in the media than Clover Health Investments. MarketBeat recorded 19 mentions for Humana and 2 mentions for Clover Health Investments. Humana's average media sentiment score of 1.05 beat Clover Health Investments' score of -0.30 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Humana 13 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Clover Health Investments (CLOV) Competitors

$4.15 +0.05 (+1.22%)

As of 08/21/2026 04:00 PM Eastern

Compare

CLOV vs. HQY, ALHC, UNH, ELV, and HUM

Should you buy Clover Health Investments stock or one of its competitors? Clover Health Investments's main competitors and comparable companies include HealthEquity (HQY), Alignment Healthcare (ALHC), UnitedHealth Group (UNH), Elevance Health (ELV), and Humana (HUM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Clover Health Investments compare to HealthEquity?

Clover Health Investments (NASDAQ:CLOV) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

HealthEquity has a net margin of 17.25% compared to Clover Health Investments' net margin of -0.74%. HealthEquity's return on equity of 14.75% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-0.74%	-4.20%	-2.28%
HealthEquity	17.25%	14.75%	9.22%

Clover Health Investments presently has a consensus target price of $4.33, indicating a potential upside of 4.42%. HealthEquity has a consensus target price of $110.93, indicating a potential upside of 5.24%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Clover Health Investments has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market.

HealthEquity has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.92B	1.15	-$85.55M	-$0.05	N/A
HealthEquity	$1.31B	6.71	$215.20M	$2.67	39.48

In the previous week, HealthEquity had 11 more articles in the media than Clover Health Investments. MarketBeat recorded 13 mentions for HealthEquity and 2 mentions for Clover Health Investments. HealthEquity's average media sentiment score of 1.40 beat Clover Health Investments' score of -0.30 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthEquity	10 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthEquity beats Clover Health Investments on 13 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Alignment Healthcare?

Alignment Healthcare (NASDAQ:ALHC) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Alignment Healthcare has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$3.95B	0.69	-$720K	$0.19	69.26
Clover Health Investments	$1.92B	1.15	-$85.55M	-$0.05	N/A

In the previous week, Alignment Healthcare had 19 more articles in the media than Clover Health Investments. MarketBeat recorded 21 mentions for Alignment Healthcare and 2 mentions for Clover Health Investments. Alignment Healthcare's average media sentiment score of 0.21 beat Clover Health Investments' score of -0.30 indicating that Alignment Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alignment Healthcare	7 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	4 Very Negative mention(s)	Neutral
Clover Health Investments	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Alignment Healthcare has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market.

Alignment Healthcare has a net margin of 0.89% compared to Clover Health Investments' net margin of -0.74%. Alignment Healthcare's return on equity of 20.02% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
Clover Health Investments	-0.74%	-4.20%	-2.28%

Alignment Healthcare currently has a consensus target price of $23.60, indicating a potential upside of 79.33%. Clover Health Investments has a consensus target price of $4.33, indicating a potential upside of 4.42%. Given Alignment Healthcare's stronger consensus rating and higher probable upside, equities analysts plainly believe Alignment Healthcare is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Alignment Healthcare beats Clover Health Investments on 13 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to UnitedHealth Group?

Clover Health Investments (NASDAQ:CLOV) and UnitedHealth Group (NYSE:UNH) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

UnitedHealth Group has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.92B	1.15	-$85.55M	-$0.05	N/A
UnitedHealth Group	$447.57B	0.78	$12.06B	$15.54	25.16

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by company insiders. Comparatively, 0.2% of UnitedHealth Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, UnitedHealth Group had 83 more articles in the media than Clover Health Investments. MarketBeat recorded 85 mentions for UnitedHealth Group and 2 mentions for Clover Health Investments. UnitedHealth Group's average media sentiment score of 1.26 beat Clover Health Investments' score of -0.30 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
UnitedHealth Group	65 Very Positive mention(s)	8 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	3 Very Negative mention(s)	Positive

UnitedHealth Group has a net margin of 3.14% compared to Clover Health Investments' net margin of -0.74%. UnitedHealth Group's return on equity of 16.53% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-0.74%	-4.20%	-2.28%
UnitedHealth Group	3.14%	16.53%	5.43%

Clover Health Investments presently has a consensus target price of $4.33, indicating a potential upside of 4.42%. UnitedHealth Group has a consensus target price of $455.92, indicating a potential upside of 16.62%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts plainly believe UnitedHealth Group is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
UnitedHealth Group	0 Sell rating(s)	5 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.89

Clover Health Investments has a beta of 2.47, meaning that its share price is 147% more volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Summary

UnitedHealth Group beats Clover Health Investments on 14 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Elevance Health?

Elevance Health (NYSE:ELV) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Elevance Health has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.47, suggesting that its stock price is 147% more volatile than the broader market.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Elevance Health had 39 more articles in the media than Clover Health Investments. MarketBeat recorded 41 mentions for Elevance Health and 2 mentions for Clover Health Investments. Elevance Health's average media sentiment score of 1.70 beat Clover Health Investments' score of -0.30 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	40 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Clover Health Investments	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Elevance Health has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.44	$5.66B	$22.50	17.81
Clover Health Investments	$1.92B	1.15	-$85.55M	-$0.05	N/A

Elevance Health presently has a consensus price target of $440.90, suggesting a potential upside of 10.04%. Clover Health Investments has a consensus price target of $4.33, suggesting a potential upside of 4.42%. Given Elevance Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Elevance Health is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Elevance Health has a net margin of 2.47% compared to Clover Health Investments' net margin of -0.74%. Elevance Health's return on equity of 14.64% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.47%	14.64%	5.22%
Clover Health Investments	-0.74%	-4.20%	-2.28%

Summary

Elevance Health beats Clover Health Investments on 13 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Humana?

Clover Health Investments (NASDAQ:CLOV) and Humana (NYSE:HUM) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

Clover Health Investments has a beta of 2.47, meaning that its share price is 147% more volatile than the broader market. Comparatively, Humana has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by insiders. Comparatively, 0.2% of Humana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Humana had 17 more articles in the media than Clover Health Investments. MarketBeat recorded 19 mentions for Humana and 2 mentions for Clover Health Investments. Humana's average media sentiment score of 1.05 beat Clover Health Investments' score of -0.30 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Humana	13 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.92B	1.15	-$85.55M	-$0.05	N/A
Humana	$129.66B	0.35	$1.19B	$10.57	35.88

Clover Health Investments presently has a consensus target price of $4.33, suggesting a potential upside of 4.42%. Humana has a consensus target price of $395.22, suggesting a potential upside of 4.22%. Given Clover Health Investments' higher possible upside, equities research analysts plainly believe Clover Health Investments is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Humana	1 Sell rating(s)	15 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.43

Humana has a net margin of 0.88% compared to Clover Health Investments' net margin of -0.74%. Humana's return on equity of 11.20% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-0.74%	-4.20%	-2.28%
Humana	0.88%	11.20%	3.94%

Summary

Humana beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLOV vs. The Competition

Export

Metric	Clover Health Investments	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.20B	$9.83B	$7.38B	$12.85B
Dividend Yield	N/A	2.55%	2.53%	10.78%
P/E Ratio	-82.98	34.38	272.60	24.21
Price / Sales	1.15	5.00	623.26	100.79
Price / Cash	N/A	125.12	78.62	53.99
Price / Book	5.85	4.05	13.05	6.20
Net Income	-$85.55M	$311.06M	$3.47B	$348.59M
7 Day Performance	-9.78%	0.83%	2.09%	0.08%
1 Month Performance	-8.79%	2.42%	6.63%	3.88%
1 Year Performance	52.01%	15.69%	25.01%	16.98%

Clover Health Investments Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLOV Clover Health Investments	1.1864 of 5 stars	$4.15 +1.2%	$4.33 +4.4%	+52.0%	$2.20B	$1.92B	N/A	680
HQY HealthEquity	3.9997 of 5 stars	$102.33 -2.3%	$110.93 +8.4%	+17.4%	$8.76B	$1.31B	38.33	2,814	News Coverage Positive News Upcoming Earnings Analyst Upgrade
ALHC Alignment Healthcare	4.3934 of 5 stars	$13.46 -3.6%	$23.60 +75.3%	-16.9%	$2.90B	$3.95B	70.85	1,849	Options Volume
UNH UnitedHealth Group	4.952 of 5 stars	$395.02 -1.7%	$455.92 +15.4%	+27.3%	$360.59B	$447.57B	25.42	390,000	Trending News Analyst Revision
ELV Elevance Health	4.8998 of 5 stars	$390.69 -2.4%	$440.90 +12.9%	+26.9%	$86.82B	$199.13B	17.36	97,100	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CLOV) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clover Health Investments (CLOV) Competitors

CLOV vs. HQY, ALHC, UNH, ELV, and HUM

How does Clover Health Investments compare to HealthEquity?

Summary

How does Clover Health Investments compare to Alignment Healthcare?

Summary

How does Clover Health Investments compare to UnitedHealth Group?

Summary

How does Clover Health Investments compare to Elevance Health?

Summary

How does Clover Health Investments compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLOV vs. The Competition

Clover Health Investments Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clover Health Investments (CLOV) Competitors

CLOV vs. HQY, ALHC, UNH, ELV, and HUM

How does Clover Health Investments compare to HealthEquity?

Is CLOV or HQY more profitable?

Do analysts rate CLOV or HQY?

Do insiders and institutionals have more ownership in CLOV or HQY?

Which has more volatility & risk, CLOV or HQY?

Which has stronger valuation & earnings, CLOV or HQY?

Does the media refer more to CLOV or HQY?

Summary

How does Clover Health Investments compare to Alignment Healthcare?

Which has preferable earnings and valuation, ALHC or CLOV?

Does the media prefer ALHC or CLOV?

Do institutionals and insiders have more ownership in ALHC or CLOV?

Which has more risk and volatility, ALHC or CLOV?

Is ALHC or CLOV more profitable?

Do analysts prefer ALHC or CLOV?

Summary

How does Clover Health Investments compare to UnitedHealth Group?

Which has better earnings & valuation, CLOV or UNH?

Do institutionals & insiders believe in CLOV or UNH?

Does the media favor CLOV or UNH?

Is CLOV or UNH more profitable?

Do analysts recommend CLOV or UNH?

Which has more risk and volatility, CLOV or UNH?

Summary

How does Clover Health Investments compare to Elevance Health?

Which has more volatility and risk, ELV or CLOV?

Do institutionals and insiders hold more shares of ELV or CLOV?

Does the media prefer ELV or CLOV?

Which has better earnings & valuation, ELV or CLOV?

Do analysts recommend ELV or CLOV?

Is ELV or CLOV more profitable?

Summary

How does Clover Health Investments compare to Humana?

Which has more volatility and risk, CLOV or HUM?

Do institutionals & insiders hold more shares of CLOV or HUM?

Does the media refer more to CLOV or HUM?

Which has better valuation and earnings, CLOV or HUM?

Do analysts prefer CLOV or HUM?

Is CLOV or HUM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLOV vs. The Competition

Clover Health Investments Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools